This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Features of advanced disease

Authoring team

The criteria for advanced phase disease include:

  • increasing splenomegaly despite full doses of cytotoxic therapy
  • rapid white cell doubling
  • white count that responds poorly to cytotoxic therapy
  • anaemia or thrombocytopenia that responds poorly to cytotoxic therapy
  • thrombocytosis >1000x10^9/l
  • 10% blasts in the blood or marrow
  • 20% (blasts + promyelocytes) in the blood or marrow
  • acquisition of "non-random" chromosomal changes in addition to the Ph chromosome
  • myelofibrosis

Reference:

  • Goldman, J. (1997). ABC of clinical haematology. BMJ. 314, 657-660.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.